Skin and stomach graft versus host disease after syngeneic BMT in CML: a case report.
暂无分享，去创建一个
[1] B. Druker,et al. Targeted CML therapy: controlling drug resistance, seeking cure. , 2006, Current opinion in genetics & development.
[2] N. Kröger,et al. Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre study , 2006, European journal of haematology.
[3] C. Thoburn,et al. Antigen-specific T-lymphocyte responses in acute and chronic syngeneic graft-versus-host disease. , 2005, Transplantation proceedings.
[4] W. Leisenring,et al. Risk factors for syngeneic graft-versus-host disease after adult hematopoietic cell transplantation. , 2004, Blood.
[5] C. Thoburn,et al. Functional divergence of antigen-specific T-lymphocyte responses in syngeneic graft-versus-host disease. , 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[6] S. Lee,et al. Autologous peripheral blood stem cell transplantation with induction of autologous graft-versus-host disease in acute myeloid leukemia , 2003, Bone Marrow Transplantation.
[7] M. Kalaycio,et al. Syngeneic graft-versus-host disease: a report of two cases and literature review , 2003, Bone Marrow Transplantation.
[8] E. Farmer,et al. Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution , 1983, The Journal of experimental medicine.